Biosearch S.A.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Granada Spain (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2011
NCT03204630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Biosearch S.A. | Bisearch Life | Mónica Olivares Martín

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Spontaneous (Phase 2)

Cardiovascular Diseases (Phase 1)

Colic (Phase 2)

Fatty Liver (Phase 2)

Hyperuricemia (Phase 1)

Infertility (Phase 3)

Inflammation (Phase 2)

Influenza, Human (Phase 2)

Insulin Resistance (Phase 2)

Liver Diseases (Phase 2)

Metabolic Syndrome (Phase 2)

Polycystic Ovary Syndrome (Phase 3)

Respiration Disorders (Phase 1)

Respiratory Tract Diseases (Phase 1)

Respiratory Tract Infections (Phase 1)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 18
  • # of Trial APIs: 13